ASML stock dips as Morgan Stanley cuts rating
Morgan Stanley analysts reduced their rating on ASML Holding (ASML) shares from Overweight to Equal-weight, and cut the price target from €925 to €800, citing “late-cycle dynamics” that could impact the company's earnings growth prospects in 2025 and 2026.
Centessa Pharmaceuticals (CNTA) upgraded to Overweight by Morgan Stanley on promising narcolepsy treatment results, stock up ...
Shares of Morgan Stanley MS shed 0.25% to $99.84 Tuesday, on what proved to be an all-around mixed trading session for the ...
MercadoLibre (NASDAQ: MELI) stock has gained renewed confidence from Wall Street, with firms like Morgan Stanley and Bank of ...
PepsiCo (NASDAQ:PEP) slipped in early trading on Friday after Morgan Stanley downgraded the food and beverage stock. The firm ...
Shares of SK Hynix Inc. plunged, leading peers lower, after Morgan Stanley cut its rating on the Korean memory chipmaker two ...
The tail end of 2024 is seeing a market shift in the stock market as the Federal Reserve has finally signaled that interest ...
Morgan Stanley is a global investment bank whose history ... now at $100.73. RSI readings suggest the stock is currently may be approaching overbought. Anticipated earnings release is in 27 days ...
Morgan Stanley was fined $2 million by a Massachusetts regulator over stock sales by a First Republic executive in the months ...
We recently compiled a list of Morgan Stanley’s Best Stock Picks: 15 Stocks To Own For 2025. In this article, we are going to ...
Key Takeaways Morgan Stanley cut its price target for Micron Technology and warned about the future of the memory chip sector ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback